Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Monoclonal antibodies as disease modifying therapy in multiple sclerosis.
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
Level of mobility limitations and falls status in persons with multiple sclerosis.
Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis.
Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis.
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
Neurologic disease with pregnancy and considerations for the obstetric anesthesiologist.
Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells.
Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation.
Vitamin D, steroid hormones, and autoimmunity.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
NG2-glia and their functions in the central nervous system.
Multiple sclerosis: Teriflunomide shows efficacy as an add-on therapy to IFN-β in patients with multiple sclerosis.
Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.
Effects of Single Bouts of Walking Exercise and Yoga on Acute Mood Symptoms in People with Multiple Sclerosis.
Influence of Cognitive Function on Speech and Articulation Rate in Multiple Sclerosis.
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study.
A case of simultaneous neuromyelitis optica spectrum disorder and subacute combined degeneration.
A Randomized Controlled Pilot Trial: The Effects of EGb 761 on Information Processing and Executive Function in Multiple Sclerosis.
Movement disorders in multiple sclerosis and other demyelinating diseases.
PGE2 contributes to in vitro MSC-mediated inhibition of non-specific- and antigen-specific T cells proliferation in MS patients.
Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis.
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2(+) Monocytes and Licenses Autoimmunity.

Pages